163 results
8-K
EX-10.4
bvetq4zvsc62zv7
1 Jun 23
Adaptimmune Announces Completion of Strategic Combination with TCR² Therapeutics Creating a Preeminent Solid Tumor Cell Therapy Company
4:09pm
8-K
3np3haz bmz
8 Apr 20
Departure of Directors or Certain Officers
8:06am
20-F
EX-4.14
jwa6yqojn5 d879xq81
13 Oct 15
Annual report (foreign)
12:00am
8-K
EX-99.1
l75 iafygnk3hxah
27 Oct 16
Adaptimmune Announces Board Changes
12:00am